Figure 4.
Proportion of convalescent patients with no detectable SARS-CoV-2 reactive T cells as determined by ELISpot analysis (n = 14) after stimulation with the various S and M peptide pools with regard to primary COVID-19 severity [n (%)].
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.